Literature DB >> 15988067

Investigation of extracellular signal-regulated kinase 2 mitogen-activated protein kinase phosphorylation and regulation of activity of PDE4 cyclic adenosine monophosphate-specific phosphodiesterases.

Elaine V Hill1, Miles D Houslay, George S Baillie.   

Abstract

Recently, it has been shown that enzymes of the cyclic adenosine monophosphate (cAMP)-specific phosphodiesterase (PDE) family 4 can be directly phosphorylated by extracellular signal-regulated kinase 2 (ERK2). Phosphorylation of PDE4s by ERK2 is dependent on two docking domains on either side of the target serine that allow specificity and high-fidelity binding of the kinase. The functional consequence of PDE4 phosphorylation by ERK is either an increase or a decrease in PDE activity, depending on whether the PDE4 contains only one of the upstream conserved regions (UCR1) that are typical of PDE4s or both (UCR1 and UCR2). We detail some of the methods that have been crucial in elucidating these important discoveries that represent a novel point of cross talk between the cAMP signaling system and the ERK mitogen-activated protein kinase cascade.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15988067     DOI: 10.1385/1-59259-839-0:225

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  PDE4D and stroke: a real advance or a case of the Emperor's new clothes?

Authors:  Bradford B Worrall; Josyf C Mychaleckyj
Journal:  Stroke       Date:  2006-07-06       Impact factor: 7.914

2.  Cytokine-induced iNOS and ERK1/2 inhibit adenylyl cyclase type 5/6 activity and stimulate phosphodiesterase 4D5 activity in intestinal longitudinal smooth muscle.

Authors:  Sunila Mahavadi; Ancy D Nalli; Divya P Kumar; Wenhui Hu; John F Kuemmerle; John R Grider; Karnam S Murthy
Journal:  Am J Physiol Cell Physiol       Date:  2014-06-18       Impact factor: 4.249

3.  Intrinsic disorder within an AKAP-protein kinase A complex guides local substrate phosphorylation.

Authors:  F Donelson Smith; Steve L Reichow; Jessica L Esseltine; Dan Shi; Lorene K Langeberg; John D Scott; Tamir Gonen
Journal:  Elife       Date:  2013-11-05       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.